# Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

> **NCT03090971** · PHASE2 · COMPLETED · sponsor: **Fundação Educacional Serra dos Órgãos** · enrollment: 7 (actual)

## Conditions studied

- Neurofibromatosis 1
- Cutaneous Neurofibroma

## Interventions

- **DRUG:** Diclofenac Sodium
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03090971
- **Lead sponsor:** Fundação Educacional Serra dos Órgãos
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2017-03-23
- **Final completion:** 2017-06-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090971, "Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03090971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*